Categories
Your selection corresponds to 45 entries
Barcelona, Spain
MWC-The ColliderWe accelerate the transfer of technology to the market, guiding research projects from opportunity validation to the development of solid and scalable deep-tech companies.

Programmes:
Opportunity Validation: 7 weeks (online). Free access to expert feedback on: Market, Intellectual Property, Tech Transfer, Team. Invitation to the Demoday with industry representatives

Business Validation: 14 weeks (hybrid). Team up with an experienced entrepreneur from our exclusive talent pool. Free access to expert feedback on: Market, Finance, Intellectual Property (Freedom-to-Operate), Regulatory, Tech Transfer, Team Roadmap, Pitching. Invitation to the Final Committee with investment representatives.

Leuven, Belgium
2005
Bio-Incubator LeuvenThe Bio-Incubator in Leuven provides a dynamic and stimulating environment for biotech companies, offering flexible office and lab space, technical support, and a network of professionals. It's located in the Leuven Arenberg Science Park, offering access to key research institutions and expertise. The Bio-Incubator supports both start-ups and established companies with strong R&D activities, facilitating the development of new technologies and products.

Facilities: The Bio-Incubator offers modular, state-of-the-art laboratory and office spaces, adaptable to the needs of young and growing companies.
Support: The incubator provides technical, logistical, and environmental support, along with expert advice from qualified staff and a professional network.
Location: Situated in the Arenberg Science Park, it's near KU Leuven, VIB research facilities, and imec, fostering collaboration and innovation.
Focus: The incubator primarily supports research-driven biotechnology companies with high growth potential.
Flexibility: The Bio-Incubator's facilities are designed to be flexible and adaptable, allowing companies to scale their operations as they grow.
Network: It provides a network of professionals and access to other biotech companies, facilitating collaboration and knowledge sharing.
Expansion: The Bio-Incubator is expanding with new buildings, like Bio-Incubator 4 and 5, to meet the growing demand for research and development space.
Leuven, Belgium
1970
University Hospital LeuvenUZ Leuven is a leading university hospital in Leuven, Belgium, known for its specialized care, research, and training in various medical fields. It focuses on delivering high-quality patient care, fostering innovation, and contributing to advancements in medical research.

What UZ Leuven does:
Patient Care: UZ Leuven provides a wide range of specialized care, including advanced procedures like fetal surgery and kidney transplants, with a focus on individual patient needs.
Medical Research: UZ Leuven is a hub for medical research, with a strong emphasis on clinical research and biomedical research. They are actively involved in clinical trials and research into various conditions, including cancer, kidney disease, and neurological disorders.
Medical Training: UZ Leuven is a major training ground for future doctors and healthcare professionals, partnering with the KU Leuven university to offer a comprehensive range of medical education programs.
Innovation and Technology: UZ Leuven invests in state-of-the-art technology and innovative treatments, including proton therapy, to improve patient outcomes.
International Collaboration: UZ Leuven actively participates in international collaborations and networks to share knowledge and expertise, contributing to advancements in global healthcare.
Infrastructure and Masterplan: UZ Leuven is implementing a masterplan to modernize its infrastructure, including new facilities for intensive care, operating theaters, and other key areas, with support from the European Investment Bank.
Wien, Austria
2024
EU-LIFE Utopia Conference 2024The EU-LIFE Utopia Conference 2024, held in Vienna on April 26, 2024, explored the potential of artificial intelligence (AI) in biology and biomedicine, focusing on a social innovation experiment. It brought together the scientific, administrative, and management communities of EU-LIFE to discuss the implications of AI in their field and envision its future. The conference included presentations on AI-driven projects and a range of perspectives on AI applications, including legal and ethical considerations.

Focus on AI: The conference's central theme was the application of AI in life sciences research, particularly in biology and biomedicine.
Social Innovation Experiment: It was framed as a social innovation experiment, meaning it aimed to explore how AI could be used to create positive societal impact within the research community.
Diverse Perspectives: The conference featured presentations from various perspectives on AI, including those from research projects, legal experts, and stakeholders in the European AI Act.
Community Engagement: It was part of a larger EU-LIFE Community Meeting in Vienna, which involved working groups and other activities.
Future Vision: The conference aimed to stimulate discussion about the future of AI in research, envisioning its potential impact on the field and beyond.
Report Published: A report summarizing the conference's key discussions and conclusions was published
Wien, Austria
2013
EU-LIFE Community Meeting 2024The EU-LIFE Community Meeting is an annual gathering for all members of the EU-LIFE alliance, a group of leading European research institutes in the life sciences. It serves as a platform for exchanging ideas, aligning strategies, and planning for the future of research in Europe. The meeting also provides an opportunity for working groups to meet and discuss best practices.

Key Purposes and Activities
Strategy Alignment: The Strategy Group (made up of the EU-LIFE board of directors, main representatives, and executive director) uses the meeting to discuss and plan for the future of research in Europe.
Best Practices Exchange: Working groups meet to share best practices in areas like core facilities, grants and funding, IT, and human resources.
Planning for the Future: The meeting allows for alignment of strategies and planning for the next year's activities.
Community Building: It fosters interaction and collaboration among all members of the EU-LIFE alliance.
Knowledge Sharing: The meeting can also include presentations and discussions on emerging topics, such as the application of artificial intelligence in life science research.
Working Groups and Task Forces: EU-LIFE has several active working groups that meet at least once a year at the community meeting to discuss specific areas of research and operations.
These working groups elect a chair who participates in strategy meetings to align activities and coordinate with other groups.

Task forces are smaller groups of experts who are brought together for specific, short-term assignments.
Cambridge, United States of America
2013
LabCentralLabCentral in Boston serves as a shared lab and office space for biotech and life science startups. It provides entrepreneurs with a fully equipped laboratory, office space, and a supportive community to help them develop and commercialize their innovations.

What LabCentral does:
Provides lab and office space: LabCentral offers a network of fully permitted laboratory and office spaces for startups, accommodating up to 125 companies with approximately 1000 scientists and entrepreneurs.
Offers equipment and resources: They provide access to a wide range of equipment and resources, including common lab equipment for bioresearch, conference rooms, event space, and kitchens.
Supports startups: LabCentral aims to empower the next generation of biotech and life science innovators by creating opportunities for them to accelerate their development of breakthrough technology and therapies.
Fosters community and networking: They foster a community of entrepreneurs and scientists, providing access to industry and investor connections.
Offers programming and events: LabCentral hosts programming and events specific to the interests of life sciences startups, as well as training on equipment and other topics.
Provides support for diversity and inclusion: LabCentral has initiatives like LabCentral Ignite to address underrepresentation in the biotech and life sciences fields, including a program called Career Forge that assesses and places talent.
Offers Golden Tickets: Sponsors can provide promising early-stage companies with a Golden Ticket, which offers $50,000 credits towards space at LabCentral's flagship site, providing access to a full range of services, equipment, and amenities.
Boston, United States of America
2009
MassChallenge BostonMassChallenge in Boston is a zero-equity startup accelerator that helps early-stage companies by providing mentorship, networking opportunities, and access to resources, all without taking any ownership stake in the businesses. It operates on a competition model, offering cash awards and other prizes to the top startups, and also provides access to a global network of experts, investors, and corporate partners.

What it does:
Accelerates startups: MassChallenge helps early-stage companies grow by providing mentorship, access to a global network of experts, and various resources.
Provides resources: They offer office space, education, and other tools to help startups succeed.
Offers cash awards: MassChallenge rewards high-impact startups with equity-free cash prizes.
Connects startups to a network: They connect startups with a network of experts, corporations, and communities to help them grow and thrive.
Focuses on impact: MassChallenge aims to identify and support entrepreneurs who are creating meaningful change and have the potential to disrupt industries.

Why it's unique:
Zero-equity: MassChallenge is a zero-equity accelerator, meaning they don't take any ownership stake in the companies they support.
Competition model: They use a competition model to identify and reward the most promising startups.
Global network: MassChallenge has a global network of experts, investors, and corporate partners, providing access to resources and opportunities beyond the Boston area.
Non-profit organization: MassChallenge is a non-profit organization, funded by corporate, public, and foundation partners.
Boston, United States of America
2016
MESH IncubatorThe MESH Incubator at Mass General Brigham is an in-house prototyping and entrepreneurship center. It focuses on rapidly developing medical solutions by combining clinical problem identification with design thinking and iterative prototyping, utilizing biodesign principles. The MESH Incubator also offers various programs and resources for clinicians, researchers, and engineers, and has actively created and supported over 2000 individuals since 2016.

What the MESH Incubator does:
1. Medical Device Development: The MESH Incubator validates needs, develops prototypes, and conducts experiments on multiple devices across various medical specialties.
They use biodesign principles and a strong emphasis on rapid development via design thinking and iterative prototyping.
They collaborate with clinicians to identify unmet needs in daily clinical practice.
2. Innovation Education and Training: The MESH Incubator offers a variety of programs and resources for clinicians, researchers, engineers, and more.
They offer a bootcamp designed to teach the fundamentals of healthcare innovation and commercialization.
They also have an online platform for innovators, the MESH Network, which includes an on-demand certificate course, Innovation Grand Rounds, and networking opportunities.
3. Startup Formation and Support: The MESH Incubator has been instrumental in forming new companies, with the MESH Innovation Teams program connecting clinicians with engineers, MBA candidates, and entrepreneurs to solve critical clinical problems.
They also provide access to Mass General Brigham and Harvard physicians, residents, faculty, experienced entrepreneurs, venture capital networking, and formal training courses in healthcare entrepreneurship.

The MESH Incubator has supported the creation of multiple startups and has produced numerous intellectual property disclosures or patents, according to their website.
Everett, United States of America
2015
World Medical Innovation ForumThe World Medical Innovation Forum is a global event that brings together healthcare leaders, industry professionals, investors, and clinicians to discuss and advance patient-benefitting technologies and innovations. It focuses on identifying and addressing the challenges and opportunities in healthcare, particularly in areas like investment, technology development, and regulatory barriers. The forum's goal is to facilitate collaboration and partnerships that drive advancements in patient care and shape the future of medicine.
It does:
Facilitates Collaboration: The forum brings together diverse stakeholders from academia, industry, healthcare providers, and finance to foster meaningful discussions and partnerships.
Identifies and Addresses Challenges: It explores the challenges in developing, investing in, and bringing new technologies to market, aiming to find solutions that benefit patients, providers, and healthcare organizations.
Highlights Innovation: The forum showcases cutting-edge medical technologies and advancements, including therapies, devices, and diagnostics.
Focuses on Key Areas: Past forums have focused on areas like oncology, rare diseases, immunology and inflammation, and generative AI.
Provides a Platform for Networking and Learning: Attendees have opportunities to network with leading experts, learn about the latest advancements, and shape the future of medicine.
Driven by Collaboration: he forum is a testament to the belief that collaborative innovation is crucial for advancing healthcare.
Hosted by Mass General Brigham: The forum is presented by Mass General Brigham in partnership with Bank of America.
Features First Look Presentations: Past events have included "First Look" presentations where Mass General Brigham innovators share their latest breakthroughs and commercial potential.
Älvsjö, Sweden
1995
BIO-EUROPE 2024BIO-Europe is a leading partnering event for the biotechnology sector in Europe, attracting major companies, pharmaceutical firms, investors, and service providers. It serves as a platform for connecting these stakeholders, facilitating thousands of bilateral meetings and fostering business development within the life sciences industry.

BIO-Europe does:
1. Facilitating Connections: It brings together over 3,700 senior executives and decision-makers from around the world, including those from academia, start-ups, and established biotechnology companies.
It organizes over 20,000 one-on-one meetings, connecting key players for potential collaborations and partnerships. It offers a partnering platform, partneringONE®, which allows delegates to schedule meetings, access content, and participate in various activities, both in-person and digitally.
2. Promoting Innovation and Insights: It features industry-leading workshops, panels, and company presentations, providing insights into the latest trends and advancements in the biotechnology sector.
It showcases innovative companies and technologies, providing a platform for startups and innovators to pitch their ideas to potential investors and partners. It offers on-demand content, including company presentations, panel discussions, and company showcases, accessible before, during, and after the event.
3. Fostering Business Development: It provides opportunities for companies to showcase their breakthroughs, build strategic relationships, and identify new business opportunities.
It helps companies increase their visibility among top-tier investors, biopharma executives, and potential partners. It offers networking events and receptions to facilitate informal interactions and relationship building.
4. Digital Partnering: BIO-Europe also includes digital partnering days, offering a virtual platform for continued collaboration and networking after the in-person event. This allows the entire global biopharma community to connect and engage, even if they cannot attend the event in person.

In essence, BIO-Europe is a comprehensive platform for the biotechnology industry, connecting key players, fostering innovation, and driving business development through a combination of in-person and digital partnering activities.
Argentina
2000
PARQUE TECNOLÓGICO DEL LITORAL CENTRO - Santa Fe - ArgentinaThe Parque Tecnológico del Litoral Centro in Santa Fe, Argentina, is an entity that seeks to promote entrepreneurship and technological innovation in the region. It offers spaces for the pre-incubation, incubation and establishment of technology-based companies, as well as facilitating interaction between the scientific, governmental and business sectors.

In detail, the Centro Tecnológico del Litoral (PTLC) carries out the following activities:
Creation of spaces: It provides physical facilities so that technology-based companies can operate and develop.
Incubation support: It offers pre-incubation and incubation programs to help businesses consolidate and grow.
Facilitation of technology transfer: It promotes collaboration between academia (universities, CONICET) and the business sector to transfer knowledge and innovation.
New business management: It helps companies manage their businesses and develop new products and services.
Development of R&D projects: It encourages research and development in collaboration with SMEs and large companies.
Participation in entrepreneurship networks: It is integrated into networks of incubators and other organizations that promote entrepreneurship.
Promotion of regional development: It seeks to boost the local and regional economy through technological entrepreneurship.

The PTLC is a Sociedad Anónima con Participación Estal Majoritaria (SAPEM), where shareholders from the scientific, governmental and business sectors of Santa Fe and the region participate
Dubai, United Arab Emirates
2022
Precision Medicine Exhibition & Summit 2024The PrecisionMed Exhibition & Summit in Dubai serves as a platform for connecting industry professionals, showcasing advancements in precision medicine, and fostering collaboration within the healthcare ecosystem. It aims to accelerate the clinical adoption of precision medicine by bringing together researchers, biotech companies, diagnostic labs, and healthcare providers. The event also provides a space for exhibitors to highlight their customized medicine technologies and services.

Connects Key Stakeholders: The summit brings together individuals and organizations involved in various aspects of precision medicine, including research, development, manufacturing, and clinical application.
Showcases Innovations: Exhibitors, including biotech and pharma companies, and diagnostic labs, present their cutting-edge products and services in precision medicine.
Promotes Clinical Adoption: The event encourages the adoption of precision medicine in clinical practice by providing a platform for discussing its benefits and challenges.
Facilitates Networking and Business Opportunities: The summit offers networking opportunities for attendees to connect with industry leaders and potential collaborators.
Focus on the Middle East Market: The summit targets the Gulf/Middle East region, recognizing the growing healthcare needs and the region's interest in precision medicine.